XA6-25340-57283
2 vaccinations
0 coded responses
7 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-09
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-03-10
- 2021-03-11
- 2021-03-12
-
2021-03-12
Call successfulParticipant prefers to complete VAERS report online
- 2021-03-14
-
2021-11-13
Dose 2 — Pfizer-BioNTech
- 2021-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-09 | Successful 2021-03-12 |
Participant prefers to complete VAERS report online |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.